# Representatives Introduce Clinical Trials Act

Representatives Jake Auchincloss and Morgan Griffith introduced the proposed Faster Clinical Trials Act on October 22, 2026. The bill would establish an FDA clinical-trial innovation center, create trial networks prioritizing community and rural care sites, and modernize trial review and research infrastructure. It identifies no solicitation, contract funding, or procurement timeline, so any contracting opportunity depends on the bill advancing and subsequent agency action.

- If enacted, the proposed center and trial networks could create future needs for clinical research services, health IT, data integration, training, and regulatory support.
- Contractors and suppliers in those areas can assess whether their capabilities align with community- and rural-site trial operations and modernized research infrastructure; the bill itself does not establish an active procurement.
- Procurement teams should distinguish this proposed legislation from a funded opportunity: no contract value, solicitation, or submission deadline is identified.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Policy
**Published:** October 24, 2026

### Government Entities
- U.S. Food and Drug Administration (FDA)
- U.S. House of Representatives

### Sources
- [Auchincloss, Griffith Introduce Faster Clinical Trials Act | U.S. Congressman Jake Auchincloss Of Massachusetts 4th District](https://auchincloss.house.gov/media/press-releases/auchincloss-griffith-introduce-faster-clinical-trials-act) - Auchincloss